Multiple protocol breaches behind anthrax exposure at CDC | The case against ‘gain-of-function’ experiments: A reply to Fouchier & Kawaoka | California’s pertussis epidemic | FDA approves two MRSA antimicrobials in a month | JIEDDO to change name as mission broadens | Empty virus-like particles as bio-compatible targeted drug-delivery vehicles | India’s anticipated uranium boost prompts alarm in Islamabad | CDC monitoring more staff after anthrax lab breach | USC to merge with Scripps? | DOE gets serious about tech transfer | Scientists condemn ‘crazy, dangerous’ creation of deadly flu virus | Communication challenges in times of an emerging public health situation | Insmed snags a surprise ‘breakthrough’ tag for up-and-down antibiotic | Counterterrorism, ethics, and global health | Nuclear forces reduced while modernizations continue | Lawmakers propose scaling back Pentagon science cuts—slightly | On the trail of drug-defying superbugs | How much did your university pay for your journals? | Inventors dash to unpack WMD threats at cellular level | FDA OKs Novartis’s US cell-based flu vaccine facility
See what we’re reading this week at Global Biodefense on topics like anthrax exposures at CDC, e-VLP for drug delivery, the Whooping Cough epidemic and more…
Multiple protocol breaches behind anthrax exposure at CDC (Reuters)
The case against ‘gain-of-function’ experiments: A reply to Fouchier & Kawaoka (CIDRAP)
California’s pertussis epidemic (Science)
FDA approves two MRSA antimicrobials in a month (Examiner)
JIEDDO to change name as mission broadens (DefenseNews)
Empty virus-like particles as bio-compatible targeted drug-delivery vehicles (BBSRC)
India’s anticipated uranium boost prompts alarm in Islamabad (NTI GSN)
CDC monitoring more staff after anthrax lab breach (CIDRAP)
USC to merge with Scripps? (The Scientist)
DOE gets serious about tech transfer (Innovation)
Scientists condemn ‘crazy, dangerous’ creation of deadly flu virus (Guardian)
Communication challenges in times of an emerging public health situation (Eurosurveillance)
Insmed snags a surprise ‘breakthrough’ tag for up-and-down antibiotic (Fierce Biotech)
Counterterrorism, ethics, and global health (Hastings Center)
Nuclear forces reduced while modernizations continue (SIPRI)
Lawmakers propose scaling back Pentagon science cuts—slightly (Science Insider)
On the trail of drug-defying superbugs (NIH)
How much did your university pay for your journals? (Science)
Inventors dash to unpack WMD threats at cellular level (NTI GSN)
FDA OKs Novartis’s US cell-based flu vaccine facility (CIDRAP)